Delivery Order SPE2DB22D3009-SPE2DB24FBF52

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The award, valued at $1,919.55, is a firm-fixed-price contract with a period of performance through September 17, 2024. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,924.84 and runs through September 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceutical and medical supplies,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,506.28, is for the delivery of BRIVIACT 100 MG TABLET 60S. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $5,115.84 contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a performance period through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,857.04 and runs through October 24, 2024. It is a Firm Fixed Price contract, with no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. This contract is...
This federal contract award, valued at $2,553.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of November 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 50 MG TABLET 60S. The $1,702.34 firm fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, through its Corporate Office Division, will provide these prescription medications to support military treatment facilities and other federal healthcare programs. This delivery order is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,104.87, is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance ending on February 5, 2025. The contract was not set aside for any particular business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $7,444.17 and an ultimate completion date of August 6, 2024. This award is not associated with any set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded various federal contracts by defense and civilian agencies to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $5,647.19 firm fixed-price contract is for the supply of 4566043652 - BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 8, 2024. AmerisourceBergen is one of the largest pharmaceutical distributors in the U.S. and has been awarded numerous federal contracts to provide a wide range of prescription...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBF52
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The firm-fixed-price contract is valued at $5,612.97 and has a period of performance through September 18, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including prescription medications, vaccines, and medical supplies, to support various government healthcare programs and military treatment facilities. The company holds several large Indefinite Delivery Contracts with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, which serve as primary vehicles for delivering essential pharmaceutical and medical products to federal agencies and beneficiaries.

Generated 12/17/24, 9:12 AM